Who invested in DTx Pharma

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$100Mraised across 1 round since 2021, from 1 source

Latest round: Series B, $100MMar 2021
Investors: 4

See who backed them

The rounds

Mar 2021
Series B$100M
Also list them on their own siteExSight Ventures
Source recordedSEC filing: $100M sold, first sale Feb 2021

Everyone who backed them

RA Capital ManagementPrivate equity1round

Janus Henderson InvestorsPrivate equity1round

Cormorant Asset ManagementPrivate equity1round

Eli LillyCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list DTx Pharma as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

ExSight VenturesVC firmSeries B, per its site

SeedFolioVC firmPer its own site

Quick answers about DTx Pharma

Who invested in DTx Pharma?

DTx Pharma's investors include RA Capital Management, Janus Henderson Investors, Cormorant Asset Management and Eli Lilly.

How much has DTx Pharma raised?

DTx Pharma has raised $100M across 1 round since 2021.

When did DTx Pharma last raise?

DTx Pharma's most recent round was a Series B of $100M in Mar 2021.

What was DTx Pharma's biggest round?

Its most recent round, $100M in Mar 2021, is also its largest on record.

Who backed DTx Pharma first?

DTx Pharma's first round on record, in Mar 2021, was backed by RA Capital Management, Janus Henderson Investors and Cormorant Asset Management and 1 others.